Biphenyl-derivatives as p38-kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S378000, C514S408000, C514S438000, C514S461000, C546S276400, C548S240000, C549S070000, C549S497000

Reexamination Certificate

active

10492715

ABSTRACT:
Compounds of formula (I):or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.

REFERENCES:
patent: 4200750 (1980-04-01), Warner et al.
patent: 4968804 (1990-11-01), Stanek et al.
patent: 5064832 (1991-11-01), Stanek et al.
patent: 5236934 (1993-08-01), VanAtten
patent: 5246943 (1993-09-01), Blankley et al.
patent: 5521213 (1996-05-01), Prasit et al.
patent: 5534518 (1996-07-01), Henrie et al.
patent: 5658903 (1997-08-01), Adams et al.
patent: 5858995 (1999-01-01), Kawai et al.
patent: 5877190 (1999-03-01), Dhainaut et al.
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 5945418 (1999-08-01), Bemis et al.
patent: 5977103 (1999-11-01), Adams et al.
patent: 6060491 (2000-05-01), Pruitt et al.
patent: 6080767 (2000-06-01), Klein et al.
patent: 6087496 (2000-07-01), Anantanarayan et al.
patent: 6130235 (2000-10-01), Mavunkel et al.
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6174887 (2001-01-01), Haruta et al.
patent: 6251914 (2001-06-01), Adams et al.
patent: 6277989 (2001-08-01), Chakravarty et al.
patent: 6323227 (2001-11-01), Klein et al.
patent: 6392047 (2002-05-01), Geissler et al.
patent: 6399627 (2002-06-01), Song et al.
patent: 6420561 (2002-07-01), Haruta et al.
patent: 6436925 (2002-08-01), Lubisch et al.
patent: 6448257 (2002-09-01), Mavunkel et al.
patent: 6451794 (2002-09-01), Beswick et al.
patent: 6498166 (2002-12-01), Campbell et al.
patent: 6509361 (2003-01-01), Weier et al.
patent: 6509363 (2003-01-01), Salituro et al.
patent: 6545054 (2003-04-01), Song et al.
patent: 6576632 (2003-06-01), Goldstein et al.
patent: 6579872 (2003-06-01), Brown et al.
patent: 6605625 (2003-08-01), Peukert et al.
patent: 6638980 (2003-10-01), Su et al.
patent: 6696464 (2004-02-01), McClure et al.
patent: 6699994 (2004-03-01), Babu et al.
patent: 6774127 (2004-08-01), Adams et al.
patent: 6794377 (2004-09-01), Peukert et al.
patent: 6821965 (2004-11-01), Brown et al.
patent: 6855719 (2005-02-01), Thomas et al.
patent: 6867209 (2005-03-01), Mavunkel et al.
patent: 6924392 (2005-08-01), Peukert et al.
patent: 6936719 (2005-08-01), Babu et al.
patent: 6956037 (2005-10-01), Brown et al.
patent: 2001/0011135 (2001-08-01), Reidl et al.
patent: 2003/0055088 (2003-03-01), Shao et al.
patent: 2003/0139605 (2003-07-01), Riedl et al.
patent: 2003/0225089 (2003-12-01), Jung et al.
patent: 2004/0038858 (2004-02-01), Dorsch et al.
patent: 2004/0053942 (2004-03-01), Alberti et al.
patent: 2004/0116479 (2004-06-01), Haviv et al.
patent: 2004/0128287 (2004-07-01), Barth et al.
patent: 2004/0162281 (2004-08-01), Babu et al.
patent: 2004/0176446 (2004-09-01), Alonso-Alija et al.
patent: 2004/0242868 (2004-12-01), Angell et al.
patent: 2004/0249161 (2004-12-01), Angell et al.
patent: 2004/0254200 (2004-12-01), Davis et al.
patent: 2004/0266839 (2004-12-01), Angell et al.
patent: 2004/0267012 (2004-12-01), Angell et al.
patent: 2005/0020540 (2005-01-01), Angell et al.
patent: 2005/0020590 (2005-01-01), Lang et al.
patent: 2005/0038014 (2005-02-01), Angell et al.
patent: 2005/0065195 (2005-03-01), Angell et al.
patent: 2005/0090491 (2005-04-01), Angell et al.
patent: 2005/0176964 (2005-08-01), Aston et al.
patent: 0 533 268 (1992-09-01), None
patent: 0 533 266 (1993-03-01), None
patent: 0 346 841 (2003-06-01), None
patent: 0 430 033 (2004-04-01), None
patent: 2 276 161 (1993-03-01), None
patent: 2 273 930 (1993-12-01), None
patent: 2 276 162 (1994-09-01), None
patent: 2 295 387 (1996-05-01), None
patent: 11218884 (1999-08-01), None
patent: WO 94/15920 (1994-07-01), None
patent: WO 95/06636 (1995-03-01), None
patent: WO 95/06644 (1995-03-01), None
patent: WO 95/11243 (1995-04-01), None
patent: WO 95/15954 (1995-06-01), None
patent: WO 95/17401 (1995-06-01), None
patent: WO 95/29907 (1995-11-01), None
patent: WO 95/30675 (1995-11-01), None
patent: WO 96/31508 (1996-10-01), None
patent: WO 96/31509 (1996-10-01), None
patent: WO 97/03034 (1997-01-01), None
patent: WO 98/57934 (1998-12-01), None
patent: WO 99/32463 (1999-07-01), None
patent: 99/59959 (1999-11-01), None
patent: 00/17175 (2000-03-01), None
patent: WO 00/12074 (2000-03-01), None
patent: WO 00/12497 (2000-03-01), None
patent: WO 00/26216 (2000-05-01), None
patent: WO 00/56738 (2000-09-01), None
patent: WO 00/71493 (2000-11-01), None
patent: WO 00/71509 (2000-11-01), None
patent: WO 00/71510 (2000-11-01), None
patent: WO 00/71511 (2000-11-01), None
patent: WO 01/27089 (2001-04-01), None
patent: WO 01/34605 (2001-05-01), None
patent: WO 01/70695 (2001-09-01), None
patent: WO 01/87875 (2001-11-01), None
patent: WO 02/40486 (2002-05-01), None
patent: WO 03/032970 (2003-04-01), None
patent: WO 03/068747 (2003-08-01), None
patent: WO 03/093248 (2003-11-01), None
patent: WO 04/010995 (2004-02-01), None
patent: WO 04/089874 (2004-10-01), None
patent: WO 04/089875 (2004-10-01), None
patent: WO 04/089876 (2004-10-01), None
patent: WO 05/014550 (2005-02-01), None
patent: WO 05/073189 (2005-08-01), None
patent: WO 05/073217 (2005-08-01), None
patent: WO 05/073219 (2005-08-01), None
patent: WO 05/073232 (2005-08-01), None
Marin et al., The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment, Aug. 1, 2001, Blood, vol. 98, No. 3, pp. 667-673, especially p. 667.
Co-pending U.S. Appl. No. 10/492,605.
Dhar et al., A Survey of Cyclic Replacements for the Central Diamide Moiety of Inhibitors of Inosine Monophosphate Dehydrogenase, Bio. & Med. Chem. Lett., vol. 12 (2002), pp. 3125-3128, especially p. 3125.
Boehm et al.,Expert Opinion of Therapeutic Patents, vol. 10 (1) pp. 25-37 (2000).
Boehm, et al.,Journal of Medicinal Chemistry, vol. 39(20) pp. 3929-3937 (1996).
Ceccarelli et al.,European Journal of Medicinal Chemistry, vol. 33 (12) pp. 943-955 (1998).
Gabriele et al.,European Journal of Organic Chemistry, vol. 2001 (24) pp. 4607-4613 (2001).
Han et al.,Biohemica et Biophysica Acta—Molecular Cell Research, vol. 1265 (2-3) pp. 224-227 (1995.
Hanson,Expert Opinion on Therapeutic Patents, vol. 7(7) pp. 729-733 (1997).
Henry et al.,Drugs of the Future, vol. 24 (12) pp. 1345-1354 (1999).
Jiang et al,Journal of Biological Chemistry, vol. 271 (30) pp. 17920-17926 (1996).
Li et al.,Biochemical and Biophysical Research Communications, vol. 228 (2) pp. 334-340 (1996).
Liebeskind et al.,Organic Letters, vol. 4 (6) pp. 979-981 (2002).
Moreland et al.,Annals of Internal Medicine, vol. 130 (6) pp. 478-486 (1999).
Murali Dhar et al.,Bioorganic and Medicinal Chemistry Letters, vol. 12 (21) pp. 3125-3128 (2002).
Rankin et al.,British Journal of Rheumatology, vol. 34 pp. 334-342 (1995).
Salituro et al.,Current Medicinal Chemistry, vol. 6 pp. 807-823 (1999).
Wang et al.,Journal of Biological Chemistry, vol. 272 (38) pp. 23668-23674 (1997).
Foster, et al., Drug News Perspect., vol. 13(8) pp. 488-497 (2000).
U.S. Appl. No. 10/513,095, filed Aug. 26, 2005, Angell et al.
U.S. Appl. No. 10/492,714, filed Apr. 15, 2004, Angell et al.
U.S. Appl. No. 10/568,121, filed Feb. 9, 2006, Walker, A.
U.S. Appl. No. 10/522,955, filed Nov. 11, 2005, Angell et al.
U.S. Appl. No. 10/551,503, filed Sep. 30, 2005, Aston, N.
U.S. Appl. No. 10/551,501, filed Sep. 30, 2005, Aston, N.
U.S. Appl. No. 10/551,502, filed Sep. 30, 2005, Aston, et al.
Boehm, et al.,Expert Opinion on Therapeutic Patents, vol. 10(1), pp. 25-37 (2000).
Courtney, S. et al.,Bioorganic&Medicinal Chemistry Letters, vol. 14 pp. 3269-3273 (2004).
Foster, et al.,Drug News Perspect., vol. 13(8) pp. 488-497 (2000).
Hanson, G., Expert Opinion on Therapeutic Patents, vol. 7(7) pp. 729-733 (1997).
Henry, et al.,Bioorganic&Medicinal Chemistry Letters, vol. 8 pp. 3335-3340 (1998).
Herlaar, et al., Molecular Medicine Today, vol. 5 pp. 439-447 (1999).
Marin, et al.,Blood, vol. 98(3) pp. 667-673 (2001).
Underwood, et al.,Journal of Pharmacology and Experimental Therapeutics, vol. 293 (1) pp. 281-288 (2000).
Wadsworth, et al., Journal of Pharmacology and Experimental Therapeutics, vol. 291(2) pp. 680-687 (1999).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Biphenyl-derivatives as p38-kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biphenyl-derivatives as p38-kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenyl-derivatives as p38-kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3829338

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.